Trial Profile
Efficacy of exenatide compared with insulin glargine in patients with type 2 diabetes using metformin or sulfonylurea for whom insulin is the next appropriate therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 02 Oct 2005 New trial record.